Embla Medical hf. Profit Margin

The latest profit margin for OSSUY is 9.45% as of September 2026. That compares with 8.6% in the prior-year period — up 9.9% year over year. That is below the sector sector average of 13.78%. Investors often review this figure alongside Embla Medical hf.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, OSSUY's profit margin moved from 8.6% to 9.45% — a 9.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Embla Medical hf.'s valuation or profitability profile.

Against its sector companies, OSSUY currently prints 9.45% for profit margin, while the sector average sits near 13.78%. That is roughly 31.4% below the sector mean. Large gaps often invite a closer look at Embla Medical hf.'s growth, margins, and balance sheet.

Profit Margin shows how effectively Embla Medical hf. converts resources into returns. At 9.45%, OSSUY may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 8.6% in the prior-year period — up 9.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting OSSUY's profit margin (9.45%), review year-over-year change from 8.6%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.